Blau H M, Epstein C J
Cell. 1979 May;17(1):95-108. doi: 10.1016/0092-8674(79)90298-8.
A system has been developed for the detailed analysis of the transition from proliferative myoblast to differentiated muscle cell. Dimethylsulfoxide (DMSO) prevents the terminal differentiation of L8 myoblasts in vitro, and its effect is reversible. DMSO (2%) inhibits the fusion of myoblasts to form multinucleate myotubes, the normal increases in activity of creatine phosphokinase (CPK) and acetylcholinesterase, and the synthesis of alpha-actin and acetylcholine receptor protein. Upon removal of DMSO from the medium, a lag precedes the onset of differentiation. The potential to inhibit muscle differentiation reversibly is not specific to DMSO, but is shared by a number of compounds, including dimethylformamide, hexamethylbisacetamide and butyric acid, all potent inducers of gene expression in Friend erythroleukemia cells. L8 cells routinely cease DNA synthesis and initiate fusion and muscle protein synthesis once they are confluent. In the presence of DMSO, however, nearly all cells continue DNA synthesis, even several days after reaching confluence. Protein synthetic patterns of DMSO-inhibited cells are almost indistinguishable from those of untreated myoblasts and distinct from differentiated myotubes. It appears that cells exposed to DMSO are locked indefinitely in a proliferative myoblast stage of development and are unable to enter the Go phase of the cell cycle necessary for initiation of differentiation. DMSO coordinately inhibits all the differentiative parameters measured. In contrast, cytochalasin B uncouples normally linked differentiative events so that fusion is inhibited while muscle-specific protein synthesis proceeds. DMSO has similar effects on both cytochalasin B-treated and fusing control cultures, suggesting that its primary effect is exerted not at the level of fusion but earlier in the differentiative time-table. Once fusion and the synthesis of muscle-specific proteins are well under way, the addition of DMSO is ineffective and differentiation continues in its presence. The potential to manipulate muscle gene expression in vitro makes this system particularly useful for the detailed analysis of the processes involved in the transition to the differentiated state and for determining the linkage of developmental events.
已开发出一种用于详细分析增殖性成肌细胞向分化肌细胞转变的系统。二甲基亚砜(DMSO)可在体外阻止L8成肌细胞的终末分化,且其作用是可逆的。2%的DMSO可抑制成肌细胞融合形成多核肌管、肌酸磷酸激酶(CPK)和乙酰胆碱酯酶活性的正常增加以及α-肌动蛋白和乙酰胆碱受体蛋白的合成。从培养基中去除DMSO后,分化开始前会有一个延迟期。可逆抑制肌肉分化的潜力并非DMSO所特有,许多化合物也具有这种能力,包括二甲基甲酰胺、六甲基双乙酰胺和丁酸,这些都是Friend红白血病细胞中基因表达的有效诱导剂。L8细胞一旦汇合,通常会停止DNA合成并开始融合及肌肉蛋白合成。然而,在DMSO存在的情况下,几乎所有细胞即使在达到汇合后数天仍继续进行DNA合成。DMSO抑制的细胞的蛋白质合成模式与未处理的成肌细胞几乎无法区分,且与分化的肌管不同。似乎暴露于DMSO的细胞被无限期锁定在增殖性成肌细胞发育阶段,无法进入启动分化所需的细胞周期G0期。DMSO协同抑制所测量的所有分化参数。相比之下,细胞松弛素B使通常相关的分化事件解偶联,从而在肌肉特异性蛋白合成进行的同时抑制融合。DMSO对细胞松弛素B处理的培养物和融合的对照培养物具有类似影响,表明其主要作用并非在融合水平发挥,而是在分化时间表中更早的时候。一旦融合和肌肉特异性蛋白的合成顺利进行,添加DMSO就无效,且在其存在的情况下分化仍会继续。体外操纵肌肉基因表达的潜力使该系统对于详细分析向分化状态转变过程中涉及的过程以及确定发育事件的联系特别有用。